Nothing Special   »   [go: up one dir, main page]

CA943126A - 4,14-estradiene compounds - Google Patents

4,14-estradiene compounds

Info

Publication number
CA943126A
CA943126A CA110,864A CA110864A CA943126A CA 943126 A CA943126 A CA 943126A CA 110864 A CA110864 A CA 110864A CA 943126 A CA943126 A CA 943126A
Authority
CA
Canada
Prior art keywords
estradiene
compounds
estradiene compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA110,864A
Other versions
CA110864S (en
Inventor
Albert Segaloff
Richard B. Gabbard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ochsner Alton Medical Foundation
Original Assignee
Ochsner Alton Medical Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ochsner Alton Medical Foundation filed Critical Ochsner Alton Medical Foundation
Application granted granted Critical
Publication of CA943126A publication Critical patent/CA943126A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
CA110,864A 1970-04-28 1971-04-20 4,14-estradiene compounds Expired CA943126A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3272370A 1970-04-28 1970-04-28
US11306771A 1971-02-05 1971-02-05

Publications (1)

Publication Number Publication Date
CA943126A true CA943126A (en) 1974-03-05

Family

ID=26708789

Family Applications (1)

Application Number Title Priority Date Filing Date
CA110,864A Expired CA943126A (en) 1970-04-28 1971-04-20 4,14-estradiene compounds

Country Status (12)

Country Link
JP (1) JPS535296B1 (en)
AR (1) AR192710A1 (en)
BE (1) BE766396A (en)
CA (1) CA943126A (en)
CH (1) CH567520A5 (en)
DE (1) DE2119708C3 (en)
DK (1) DK128209B (en)
ES (1) ES390645A1 (en)
FR (1) FR2092103A1 (en)
IL (1) IL36628A (en)
NL (1) NL7105798A (en)
SE (1) SE379356B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10351587B2 (en) 2000-03-31 2019-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE334682T1 (en) 2000-03-31 2006-08-15 Us Gov Health & Human Serv METHOD FOR PRODUCING THE TRANS-4-N-BUTYLCYCLOHEXANOICSIC ACID AND UNDECANOICSIC ACID ESTERS OF (7-ALPHA,11-BETA)-DIMETHYL-17 BETA -HYDROXY-4-ESTREN-3-ONE AND THEIR MEDICAL APPLICATION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374228A (en) * 1965-10-25 1968-03-19 Syntex Corp 14beta-estra-1, 3, 5(10)-trienes
US3467682A (en) * 1967-04-28 1969-09-16 Searle & Co 13beta-alkyl-17alpha-alkynylgon-4-ene-3beta,17beta-diols and esters corresponding

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10351587B2 (en) 2000-03-31 2019-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

Also Published As

Publication number Publication date
SE379356B (en) 1975-10-06
AR192710A1 (en) 1973-03-14
JPS535296B1 (en) 1978-02-25
DE2119708B2 (en) 1980-07-17
DK128209B (en) 1974-03-18
NL7105798A (en) 1971-11-01
FR2092103B1 (en) 1975-10-10
DE2119708A1 (en) 1971-11-11
BE766396A (en) 1971-10-28
IL36628A0 (en) 1971-06-23
FR2092103A1 (en) 1972-01-21
DE2119708C3 (en) 1981-10-08
ES390645A1 (en) 1974-04-01
CH567520A5 (en) 1975-10-15
IL36628A (en) 1978-08-31

Similar Documents

Publication Publication Date Title
CA1021352A (en) Substituted 2-aminomethyl-4,6-dihalophenols
AU470566B2 (en) 3, 5-dioxopiperazine derivatives
CA1010890A (en) Fluoroalkylsulfonamidoaryl compounds
CA965104A (en) 3,4,5-trialkylcyclohexanols
ZA712312B (en) 4,14-estradiene compounds
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
CA943126A (en) 4,14-estradiene compounds
CA837636A (en) 1,3-diazacyclo-2,4-butanediones
AU3151271A (en) Substituted 1, 3-indandiols
AU464322B2 (en) 4, 14-estradiene compounds
AU2775471A (en) 4, 14-estradiene compounds
CA838693A (en) 1,2-dihydro-1-hydroxypyrimidines
CA858562A (en) 2-halo-3,11,20-triketo-17-hydroxy-21-acyloxy-pregnanes
CA831547A (en) 2,6-diarylphenols
CA854718A (en) 1,2-dihydro-1-hydroxypyrimidines
CA854194A (en) 2,3,1-diazaborines
CA851181A (en) 2,2-ethylenetestosterones
AU440569B2 (en) 1,2,6b,7b-DIMETHYLENE-STEROIDS
CA839720A (en) 2-aryl-1-oxa-3-azaspiro (5,5) undec-2-enes
CA836581A (en) 2'3'-di-deoxyriboside-2',3'-olefins
CA838136A (en) 1,2-dihydro-1-hydroxy-2-imino-6-lower alkylpyrimidine derivatives
CA838135A (en) 1,2-dihydro-1-hydroxy-2-imino-6-lower alkylpyrimidine derivatives
CA838137A (en) 1,2-dihydro-1-hydroxy-2-imino-5-nitro-pyrimidine derivatives
CA838144A (en) 1,2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidine derivatives
CA834198A (en) Benzoxazolyl-1,3,4-oxdiazole derivatives